Histone deacetylases (HDACs) play an important role in the epigenetic regulation of gene expression by catalyzing the removal of acetyl groups from lysine residue of histone protein, stimulating chromatin condensation and promoting transcriptional repression. 1,2 HDACs are divided into four classes on the basis of their homology to yeast HDACs: class I (HDAC1, 2, 3 and 8), class IIa (HDAC4, 5, 7 and 9), class IIb (HDAC6 and 10), class III (SIRT1, 2, 3, 4, 5, 6 and 7) and class IV (HDAC11). As aberrant epigenetic changes are a hallmark of cancer, HDACs are a promising target for an anticancer drug. The inhibitors of HDACs can induce cell-cycle arrest, promote differentiation and stimulate tumor cell death. In fact, several HDAC inhibitors are currently in clinical trials both for solid and hematological malignancies. 1,2 Therefore, we attempted to search new HDAC inhibitors. As a result, we isolated a novel compound designated as JBIR-17 (1) from Streptomyces sp. 26634 (Figure 1 ). We report herein the isolation, structure elucidation and biological activity of 1.
XBridge Prep C 18 column (5 mm optimum bed density (OBD), 4.6 i.d.Â250 mm, Waters, Milford, MA, USA) with 35% aqueous CH 3 CN containing 0.2% formic acid (flow rate, 1 ml min -1 ) to yield JBIR-17 (1, 0.9 mg; retention time (Rt) 9.7 min) and trichostatin A (2, 0.7 mg; Rt 10.3 min). 3 The physicochemical properties of 1 are summarized in Table 1 . Compound 1 was obtained as a colorless amorphous solid, and its molecular formula was determined to be C 20 H 26 N 2 O 5 by HR-electrospray ionization (ESI)-MS. The IR spectrum revealed the characteristic absorptions of the aroyl and/or amide carbonyl (n max 1652 cm -1 ) and amide N-H (n max 1597 cm À1 ) groups. The structure of 1 was mainly determined by NMR spectral analyses as follows.
The direct connectivity between each proton and carbon was established by the heteronuclear single quantum coherence spectrum, and the 13 C and 1 H NMR spectral data for 1 are shown in Table 2 . A total of 20 signals were observed in the 13 C NMR spectrum, consistent with the HR-MS data. These signals included three carbonyl (C-1, C-7, C-1¢), four olefinic (C-2 to C-5) and six aromatic (C-8 to C-13) carbons. The proton spin couplings between two olefinic protons 2-H (d H 5.91) and 3-H (d H 7.28), between an olefinic proton 5-H (d H 6.04) and a methyl proton 6-Me (d H 1.28) through a methine proton 6-H (d H 4.36), and between two equivalent aromatic protons 9,13-H (d H 7.84) and 10,12-H (d H 6.69) on a p-disubstituted benzene ring were observed in a double-quantum filtered (DQF)-COSY spectrum as shown in Figure 2 A long-range coupling from 3¢-H to a carboxylic carbonyl carbon C-1¢ deduced that the remaining structure was a serine moiety, and the serine was assumed to attach to C-1 of trichostatin through an amide bond.
The linkage position and the absolute configuration of the serine moiety of 1 were confirmed as follows. To determine the absolute configuration of the serine moiety, Marfey's method was adopted. Compound 1 (0.8 mg) was hydrolyzed with 6 N HCl (0.2 ml) at 1201C overnight to obtain the serine residue. After acid hydrolysis, the reaction solution was adjusted to neutral pH and evaporated in vacuo. The residue was dissolved in an aqueous solution of 0.1 M NaHCO 3 (0.6 ml), and 10 mM N a -(5-fluoro-2,4-dinitrophenyl)-Lalaninamide (FDAA) in Me 2 CO (0.6 ml) was successively added. The mixture was kept at 701C for 10 min with frequent shaking. After work-up with the addition of 0.2 N HCl, the filtered reaction mixture was subjected to ultra performance liquid chromatography (UPLC) analysis (Acquity UPLC BEH C 18 1.7 mm, 2.1Â50 mm, Waters; 10% aqueous CH 3 CN containing 0.1% formic acid; flow rate, 0.3 ml min -1 ). The authentic D-and L-serine were reacted with FDAA in the same manner as described above. The serine residue obtained from the hydrolysate was determined to be L-serine (Rt 8.6 min; L-Ser, 8.5 min; D-Ser, 9.8 min). To confirm the linkage position of serine moiety, 1 was semi-synthesized from 2 as shown in Figure 3 . Briefly, 2 (7.5 mg) was converted to 3 (3.4 mg) by HClO 4 . Compound 3 was coupled with an O-t-butyl-L-serine t-butyl ester in the presence of PyBOP and N,N-diisopropylethylamine followed by deprotection in acidic condition to yield an L-serine adduct of 3 (0.9 mg). This synthetic compound showed an identical 1 H NMR spectrum to that of naturally isolated 1 from Streptomyces sp. 26634.
To evaluate inhibitory activity for HDACs of 1, we used the reporter gene assay system using a luciferase gene as described earlier. 5, 6 The human embryonic kidney 293T cells, transformed with the luciferase reporter gene driven by the cytomegalovirus promoter, produced 2.5 times more luciferase compared with the untreated control, when they were treated with 1 at a concentration of 30 mM. Furthermore, to clarify the selectivity against HDAC subtypes, 1 was tested in the HDAC inhibitory activity using HDAC1 (class I), 4 (class IIa) and 6 (class IIb) enzymes of 293T cell origin, which are usually used as the representative HDACs among each HDAC subtype. 7 Compound 1 showed inhibitory activity against HDAC4 and 6 with IC 50 values of 69 and 4.7 mM, respectively, but no activity against HDAC1 at a Abbreviation: ESI, electrospray ionization. a Optical rotation was measured on a SEPA-300 polarimeter (Horiba, Kyoto, Japan). b HR-ESI-MS measurement was carried out on a LCT Premier XE mass spectrometer (Waters). c UV spectrum was measured on a COULTER DU730 UV/Vis Spectrophotometer (Beckman, Fullerton, CA, USA). d IR spectra was obtained on a FT-720 Fourier transform infrared spectrometer (Horiba). JBIR-17, a novel trichostatin analog J-y Ueda et al concentration of 100 mM. In contrast, 2 showed strong, but not selective, inhibitory effects against these HDACs (IC 50 values, 18, 30 and 92 nM against HDAC1, 4 and 6, respectively) as reported earlier. 8, 9 These results indicated that 1 selectively inhibited HDAC6 compared with HDAC1 and 4. HDAC6 is a cytoplasmic enzyme that regulates many important biological processes, including cell migration, immune synapse formation, viral infection and the degradation of misfolded proteins. Furthermore, HDAC6 deacetylates tubulin, Hsp90 and cortactin. [10] [11] [12] The diverse functions of HDAC6 suggest that it is a potential therapeutic target for a wide range of diseases. Thus, JBIR-17 could be a valuable tool for the studies of HDAC6 and enzymatic property among HDAC subtypes. 
